mTOR ATP-competitive inhibitor INK128 inhibits neuroblastoma growth via blocking mTORC signaling
Zhang, HY (Zhang, Huiyuan); Dou, J (Dou, Jun); Yu, Y (Yu, Yang); Zhao, YL (Zhao, Yanling); Fan, YH (Fan, Yihui); Cheng, J (Cheng, Jin); Xu, X (Xu, Xin); Liu, W (Liu, Wei); Guan, S (Guan, Shan); Chen, ZH (Chen, Zhenghu); Shi, Y (Shi, Yan); Patel, R (Patel, Roma); Vasudevan, SA (Vasudevan, Sanjeev A.); Zage, PE (Zage, Peter E.); Zhang, H (Zhang, Hong); Nuchtern, JG (Nuchtern, Jed G.); Kim, ES (Kim, Eugene S.); Fu, SB (Fu, Songbin); Yang, JH (Yang, Jianhua)
2015
发表期刊APOPTOSIS
ISSN1360-8185
卷号20期号:1页码:50-62
摘要

High-risk neuroblastoma often develops resistance to high-dose chemotherapy. The mTOR signaling cascade is frequently deregulated in human cancers and targeting mTOR signaling sensitizes many cancer types to chemotherapy. Here, using a panel of neuroblastoma cell lines, we found that the mTOR inhibitor INK128 showed inhibitory effects on both anchorage-dependent and independent growth of neuroblastoma cells and significantly enhanced the cytotoxic effects of doxorubicin (Dox) on these cell lines. Treatment of neuroblastoma cells with INK128 blocked the activation of downstream mTOR signaling and enhanced Dox-induced apoptosis. Moreover, INK128 was able to overcome the established chemoresistance in the LA-N-6 cell line. Using an orthotopic neuroblastoma mouse model, we found that INK128 significantly inhibited tumor growth in vivo. In conclusion, we have shown that INK128-mediated mTOR inhibition possessed substantial antitumor activity and could significantly increase the sensitivity of neuroblastoma cells to Dox therapy. Taken together, our results indicate that using INK128 can provide additional efficacy to current chemotherapeutic regimens and represent a new paradigm in restoring drug sensitivity in neuroblastoma.

关键词Neuroblastoma Mtor Inhibitor Ink128 Chemotherapy Drug Resistance
DOI10.1007/s10495-014-1066-0
收录类别SCI
WOS记录号WOS:000347528900005
引用统计
文献类型期刊论文
条目标识符http://ir.xjipc.cas.cn/handle/365002/4215
专题省部共建新疆特有药用资源利用重点实验室
作者单位Harbin Med Univ, Labratory Med Genet, Harbin 150081, Heilongjiang, Peoples R China;Baylor Coll Med, Dan L Duncan Canc Ctr, Dept Pediat, Texas Childrens Canc Ctr, Houston, TX 77030 USA;Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA;Chinese Acad Sci, Xinjiang Tech Inst Phys & Chem, Xinjiang Key Lab Plant Resources & Nat Prod Chem, Urumqi 830011, Xinjiang, Peoples R China;Baylor Coll Med, Dan L Duncan Canc Ctr, Michael E DeBakey Dept Surg, Div Pediat Surg, Houston, TX 77030 USA
推荐引用方式
GB/T 7714
Zhang, HY ,Dou, J ,Yu, Y ,et al. mTOR ATP-competitive inhibitor INK128 inhibits neuroblastoma growth via blocking mTORC signaling[J]. APOPTOSIS,2015,20(1):50-62.
APA Zhang, HY .,Dou, J .,Yu, Y .,Zhao, YL .,Fan, YH .,...&Yang, JH .(2015).mTOR ATP-competitive inhibitor INK128 inhibits neuroblastoma growth via blocking mTORC signaling.APOPTOSIS,20(1),50-62.
MLA Zhang, HY ,et al."mTOR ATP-competitive inhibitor INK128 inhibits neuroblastoma growth via blocking mTORC signaling".APOPTOSIS 20.1(2015):50-62.
条目包含的文件
文件名称/大小 文献类型 版本类型 开放类型 使用许可
mTOR ATP-competitive(1334KB)期刊论文作者接受稿开放获取CC BY-NC-SA浏览 请求全文
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Zhang, HY (Zhang, Huiyuan)]的文章
[Dou, J (Dou, Jun)]的文章
[Yu, Y (Yu, Yang)]的文章
百度学术
百度学术中相似的文章
[Zhang, HY (Zhang, Huiyuan)]的文章
[Dou, J (Dou, Jun)]的文章
[Yu, Y (Yu, Yang)]的文章
必应学术
必应学术中相似的文章
[Zhang, HY (Zhang, Huiyuan)]的文章
[Dou, J (Dou, Jun)]的文章
[Yu, Y (Yu, Yang)]的文章
相关权益政策
暂无数据
收藏/分享
文件名: mTOR ATP-competitive inhibitor INK128 inhibits neuroblastoma growth via blocking mTORC signaling.pdf
格式: Adobe PDF
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。